Perspective Therapeutics CATX Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Perspective Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent.
The official record: Perspective Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Perspective Therapeutics's accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Perspective Therapeutics's accounts payable?
- Perspective Therapeutics (CATX) reported accounts payable of $26.49M in Q1 2026.
- How has Perspective Therapeutics's accounts payable changed year-over-year?
- Perspective Therapeutics's accounts payable increased by 203.2% year-over-year, from $8.73M to $26.49M.
- What is the long-term trend for Perspective Therapeutics's accounts payable?
- Over 5 years (2020 to 2025), Perspective Therapeutics's accounts payable has grown at a 110.7% compound annual growth rate (CAGR), from $494K to $20.51M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.